INS and Hypoglycemia: To address this, we used a rodent STZ-induced type 1 diabetes model with basal insulin replacement and controlled recurrent hypoglycaemia, which allows better modelling of the human experience of hypoglycaemia and permits in vivo and ex vivo analysis.